FIGURE 1 FIGURE 2 4 Evaluation of the efficacy and safety of tirzepatide in the treatment of type 2 diabetes and cardiovascular risk management 4.1 SURPASS-1: efficacy of tirzepatide on HbA1c and weight change The SURPASS-1 trial included 478 patients and compared the efficacy of tirzepatide at doses of 5 mg, 10 mg, and 15 mg
However, the sublingual route avoids first-pass metabolism by the liver, potentially altering the pharmacokinetic profile and leading to greater variability in absorption compared to injectable forms
In a broader sense, the set of reactions occurring within the cells is called intermediary (or intermediate) metabolism
Amino terminal Cu(II)- and Ni(II)-binding (ATCUN) motif of proteins and peptides: metal binding, DNA cleavage, and other properties
[PubMed] 327.Kim J, Kim BE, Leung DYM